{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:20Z","timestamp":1782604820366,"version":"3.54.5"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pharmacist prescribing is expanding across care settings, supported by pharmacists\u2019 expertise in pharmacology, therapeutics, disease management, and medication optimization. In settings where pharmacists can prescribe, patients and providers report positive outcomes. However, limited research has examined pharmacist prescribing in dialysis centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study explored patient and clinician perspectives on potential pharmacist prescribing in the outpatient hemodialysis unit at Toronto General Hospital, University Health Network (TGH-UHN) in Toronto, Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Semi-structured, one-on-one interviews were conducted with English-speaking adults receiving hemodialysis, and clinicians, including nephrologists, pharmacists, dietitians, and nurse practitioners in the outpatient hemodialysis unit at TGH-UHN. Patient interviews focused on experiences receiving and filling prescriptions, interactions with pharmacists in the hemodialysis unit, and views on potential pharmacist prescribing in the unit. Clinician interviews explored the strengths and limitations of the current prescribing process in the hemodialysis unit, pharmacists\u2019 role in the unit, perceived benefits and challenges of potential pharmacist prescribing, and strategies for implementation. Participants were recruited through convenience sampling until data saturation was reached. Interviews were audio-recorded, transcribed, and analyzed thematically using an inductive approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eleven patients and 11 clinicians (six nephrologists, two pharmacists, two dietitians, and one nurse practitioner) were interviewed in June and July 2025. Reported challenges of the current prescribing process included communication gaps and delays in care, while accessibility of prescribers and interdisciplinary collaboration were identified as strengths. Pharmacists were recognized as valuable care team members for their expertise in medication management and rapport with patients. Anticipated benefits of pharmacist prescribing included improved medication optimization, workflow efficiency, timely care, and pharmaco-economic savings. Limited prescribing knowledge among some pharmacists was noted as a barrier. Implementation considerations included a collaborative approach, maintaining physician oversight, restricting prescribing to specific clinical areas, phased rollout, patient and clinician buy-in, adequate resources, and clearly defined roles and communication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients and clinicians were generally supportive of potential pharmacist prescribing in the hemodialysis unit, contingent on several considerations for implementation. Interviews with additional stakeholders in other dialysis care settings could further inform strategies for broader adoption.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-025-02084-x","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T05:38:18Z","timestamp":1768628298000},"page":"886-896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perspectives on potential pharmacist prescribing in an outpatient dialysis center: qualitative interviews with patients and clinicians"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3418-7691","authenticated-orcid":false,"given":"Angela S.","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3914-0760","authenticated-orcid":false,"given":"Madeline","family":"Theodorlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0590-8903","authenticated-orcid":false,"given":"Angelina","family":"Abbaticchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-4365","authenticated-orcid":false,"given":"Marisa","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"key":"2084_CR1","unstructured":"Annual statistics on organ replacement in Canada, 2012 to 2021. Canadian Institute for Health Information. 2023. https:\/\/www.cihi.ca\/en\/annual-statistics-on-organ-replacement-in-canada-2012-to-2021. Accessed 26 Mar 2025."},{"key":"2084_CR2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00290109","author":"Y-W Chiu","year":"2009","unstructured":"Chiu Y-W, Teitelbaum I, Misra M, et al. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009. https:\/\/doi.org\/10.2215\/CJN.00290109.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2084_CR3","doi-asserted-by":"publisher","DOI":"10.5414\/CN108654","author":"M Battistella","year":"2016","unstructured":"Battistella M, Fleites R, Wong R, et al. Development, validation, and implementation of a medication adherence survey to seek a better understanding of the hemodialysis patient. Clin Nephrol. 2016. https:\/\/doi.org\/10.5414\/CN108654.","journal-title":"Clin Nephrol"},{"key":"2084_CR4","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50048","author":"HJ Manley","year":"2003","unstructured":"Manley HJ, McClaran ML, Overbay DK, et al. Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis. 2003. https:\/\/doi.org\/10.1053\/ajkd.2003.50048.","journal-title":"Am J Kidney Dis"},{"key":"2084_CR5","first-page":"456","volume":"15","author":"I Tang","year":"1993","unstructured":"Tang I, Vrahnos D, Hatoum H, et al. Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther. 1993;15:456\u201364.","journal-title":"Clin Ther"},{"key":"2084_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-016-0317-2","author":"B Qudah","year":"2016","unstructured":"Qudah B, Albsoul-Younes A, Alawa E, et al. Role of clinical pharmacist in the management of blood pressure in dialysis patients. Int J Clin Pharm. 2016. https:\/\/doi.org\/10.1007\/s11096-016-0317-2.","journal-title":"Int J Clin Pharm"},{"key":"2084_CR7","unstructured":"Regulated health professions. Government of Ontario. 2023. https:\/\/www.ontario.ca\/page\/regulated-health-professions. Accessed 28 Aug 2025"},{"key":"2084_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2020.11.015","author":"C Daifi","year":"2021","unstructured":"Daifi C, Feldpausch B, Roa P-A, et al. Implementation of a clinical pharmacist in a hemodialysis facility: a quality improvement report. Kidney Med. 2021. https:\/\/doi.org\/10.1016\/j.xkme.2020.11.015.","journal-title":"Kidney Med"},{"key":"2084_CR9","doi-asserted-by":"publisher","DOI":"10.1681\/asn.20203110s1392a","author":"O Thwin","year":"2021","unstructured":"Thwin O, Han M, Tao X, et al. Feasibility study of wrist-based wearable activity tracker in hemodialysis patients. J Am Soc Nephrol. 2021. https:\/\/doi.org\/10.1681\/asn.20203110s1392a.","journal-title":"J Am Soc Nephrol"},{"key":"2084_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2022.05.005","author":"M Ogilvie","year":"2022","unstructured":"Ogilvie M, Nissen L, Kyle G, et al. An evaluation of a collaborative pharmacist prescribing model compared to the usual medical prescribing model in the emergency department. Res Social Adm Pharm. 2022. https:\/\/doi.org\/10.1016\/j.sapharm.2022.05.005.","journal-title":"Res Social Adm Pharm"},{"key":"2084_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/ijpp.12674","author":"K Bondurant-David","year":"2020","unstructured":"Bondurant-David K, Dang S, Levy S, et al. Issues with deprescribing in haemodialysis: a qualitative study of patient and provider experiences. Int J Pharm Pract. 2020. https:\/\/doi.org\/10.1111\/ijpp.12674.","journal-title":"Int J Pharm Pract"},{"key":"2084_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/ppar\/pry030","author":"A Linsky","year":"2018","unstructured":"Linsky A, Zimmerman KM. Provider and system-level barriers to deprescribing: interconnected problems and solutions. Public Policy Aging Report. 2018. https:\/\/doi.org\/10.1093\/ppar\/pry030.","journal-title":"Public Policy Aging Report"},{"key":"2084_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxac190","author":"S Gerardi","year":"2022","unstructured":"Gerardi S, Sperlea D, Levy SOL, et al. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis. Am J Health Syst Pharm. 2022. https:\/\/doi.org\/10.1093\/ajhp\/zxac190.","journal-title":"Am J Health Syst Pharm"},{"key":"2084_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-022-01449-w","author":"SC Trenaman","year":"2022","unstructured":"Trenaman SC, Kennie-Kaulbach N, d\u2019Entremont-MacVicar E, et al. Implementation of pharmacist-led deprescribing in collaborative primary care settings. Int J Clin Pharm. 2022. https:\/\/doi.org\/10.1007\/s11096-022-01449-w.","journal-title":"Int J Clin Pharm"},{"key":"2084_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2024.04.014","author":"A Kassis","year":"2024","unstructured":"Kassis A, Moles R, Carter S. Stakeholders\u2019 perspectives and experiences of the pharmacist\u2019s role in deprescribing in ambulatory care: a qualitative meta-synthesis. Res Social Adm Pharm. 2024. https:\/\/doi.org\/10.1016\/j.sapharm.2024.04.014.","journal-title":"Res Social Adm Pharm"},{"key":"2084_CR16","doi-asserted-by":"publisher","DOI":"10.1691\/ph.2022.2323","author":"E Kose","year":"2022","unstructured":"Kose E, Endo H, Hori H, et al. Association of pharmacist-led deprescribing intervention with the functional recovery in convalescent setting. Pharmazie. 2022. https:\/\/doi.org\/10.1691\/ph.2022.2323.","journal-title":"Pharmazie"},{"key":"2084_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/08971900221097246","author":"M Chan","year":"2023","unstructured":"Chan M, Plakogiannis R, Stefanidis A, et al. Pharmacist-led deprescribing for patients with polypharmacy and chronic disease states: a retrospective cohort study. J Pharm Pract. 2023. https:\/\/doi.org\/10.1177\/08971900221097246.","journal-title":"J Pharm Pract"},{"key":"2084_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/1715163519836136","author":"A Elbeddini","year":"2019","unstructured":"Elbeddini A, Zhang CXY. The pharmacist\u2019s role in successful deprescribing through hospital medication reconciliation. Can Pharm J\/Revue des Pharmaciens du Canada. 2019. https:\/\/doi.org\/10.1177\/1715163519836136.","journal-title":"Can Pharm J\/Revue des Pharmaciens du Canada"},{"key":"2084_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/17151635211014918","author":"E Lui","year":"2021","unstructured":"Lui E, Wintemute K, Muraca M, et al. Pharmacist-led sedative-hypnotic deprescribing in team-based primary care practice. Can Pharm J\/Revue des Pharmaciens du Canada. 2021. https:\/\/doi.org\/10.1177\/17151635211014918.","journal-title":"Can Pharm J\/Revue des Pharmaciens du Canada"},{"key":"2084_CR20","doi-asserted-by":"publisher","DOI":"10.54133\/ajms.v5i1S.290","author":"MJ Falah","year":"2023","unstructured":"Falah MJ, Jasim AL. The impact of implementing a pharmacist-led deprescribing program on medication adherence among hemodialysis patients. Al-Rafidain J Med Sci. 2023. https:\/\/doi.org\/10.54133\/ajms.v5i1S.290.","journal-title":"Al-Rafidain J Med Sci"},{"key":"2084_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2014.08.021","author":"JL Kuntz","year":"2014","unstructured":"Kuntz JL, Safford MM, Singh JA, et al. Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings. Patient Educ Couns. 2014. https:\/\/doi.org\/10.1016\/j.pec.2014.08.021.","journal-title":"Patient Educ Couns"},{"key":"2084_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-014-9982-1","author":"LM Okumura","year":"2014","unstructured":"Okumura LM, Rotta I, Correr CJ. Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review. Int J Clin Pharm. 2014. https:\/\/doi.org\/10.1007\/s11096-014-9982-1.","journal-title":"Int J Clin Pharm"},{"key":"2084_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/00469580231219457","author":"YB Tadesse","year":"2023","unstructured":"Tadesse YB, Sendekie AK, Mekonnen BA, et al. Pharmacists\u2019 medication counseling practices and knowledge and satisfaction of patients with an outpatient hospital pharmacy service. Inquiry. 2023. https:\/\/doi.org\/10.1177\/00469580231219457.","journal-title":"Inquiry"},{"key":"2084_CR24","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2020.4.2171","author":"T Raiche","year":"2020","unstructured":"Raiche T, Pammett R, Dattani S, et al. Community pharmacists\u2019 evolving role in Canadian primary health care: a vision of harmonization in a patchwork system. Pharm Pract (Granada). 2020. https:\/\/doi.org\/10.18549\/PharmPract.2020.4.2171.","journal-title":"Pharm Pract (Granada)"},{"key":"2084_CR25","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-23919","author":"M Aghili","year":"2021","unstructured":"Aghili M, Kasturirangan MN. Management of drug\u2013drug interactions among critically ill patients with chronic kidney disease: impact of clinical pharmacist\u2019s interventions. Indian J Crit Care Med. 2021. https:\/\/doi.org\/10.5005\/jp-journals-10071-23919.","journal-title":"Indian J Crit Care Med"},{"key":"2084_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2017-000687","author":"S Omboni","year":"2018","unstructured":"Omboni S, Caserini M. Effectiveness of pharmacist\u2019s intervention in the management of cardiovascular diseases. Open Heart. 2018. https:\/\/doi.org\/10.1136\/openhrt-2017-000687.","journal-title":"Open Heart"},{"key":"2084_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/2042098617693546","author":"D Stewart","year":"2017","unstructured":"Stewart D, Jebara T, Cunningham S, et al. Future perspectives on nonmedical prescribing. Ther Adv Drug Saf. 2017. https:\/\/doi.org\/10.1177\/2042098617693546.","journal-title":"Ther Adv Drug Saf"},{"key":"2084_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2019.06.009","author":"T Jebara","year":"2020","unstructured":"Jebara T, Cunningham S, Maclure K, et al. Key stakeholders\u2019 views on the potential implementation of pharmacist prescribing: a qualitative investigation. Res Social Adm Pharm. 2020. https:\/\/doi.org\/10.1016\/j.sapharm.2019.06.009.","journal-title":"Res Social Adm Pharm"},{"key":"2084_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13624","author":"T Jebara","year":"2018","unstructured":"Jebara T, Cunningham S, Maclure K, et al. Stakeholders\u2019 views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol. 2018. https:\/\/doi.org\/10.1111\/bcp.13624.","journal-title":"Br J Clin Pharmacol"},{"key":"2084_CR30","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080247","author":"N Yuksel","year":"2008","unstructured":"Yuksel N, Eberhart G, Bungard TJ. Prescribing by pharmacists in Alberta. Am J Health-Syst Pharm. 2008. https:\/\/doi.org\/10.2146\/ajhp080247.","journal-title":"Am J Health-Syst Pharm"},{"key":"2084_CR31","unstructured":"Prescribing authority of pharmacists across Canada. Canadian Pharmacists Association. 2025. https:\/\/www.pharmacists.ca\/cpha-ca\/assets\/File\/pharmacy-in-canada\/PharmacistPrescribingAuthority_EN_web.pdf. Accessed 26 Mar 2025."},{"key":"2084_CR32","unstructured":"Ontario pharmacists now authorized to prescribe for minor ailments. Ontario College of Pharmacists. 2023. https:\/\/www.ocpinfo.com\/ontario-pharmacists-now-authorized-to-prescribe-for-minor-ailments\/. Accessed 26 Mar 2025."},{"key":"2084_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-024-01794-y","author":"F Al Raiisi","year":"2024","unstructured":"Al Raiisi F, Cunningham S, Stewart D. A qualitative, theory-based exploration of facilitators and barriers for implementation of pharmacist prescribing in chronic kidney disease. Int J Clin Pharm. 2024. https:\/\/doi.org\/10.1007\/s11096-024-01794-y.","journal-title":"Int J Clin Pharm"},{"key":"2084_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2019.08.004","author":"KR Majercak","year":"2019","unstructured":"Majercak KR. Advancing pharmacist prescribing privileges: is it time? J Am Pharm Assoc. 2019. https:\/\/doi.org\/10.1016\/j.japh.2019.08.004.","journal-title":"J Am Pharm Assoc"},{"key":"2084_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxz059","author":"KL Ryan","year":"2019","unstructured":"Ryan KL, Jakeman B, Conklin J, et al. Treatment of patients with HIV or hepatitis C by pharmacist clinicians in a patient-centered medical home. Am J Health-Syst Pharm. 2019. https:\/\/doi.org\/10.1093\/ajhp\/zxz059.","journal-title":"Am J Health-Syst Pharm"},{"key":"2084_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2024.01.006","author":"RL Walpola","year":"2024","unstructured":"Walpola RL, Issakhany D, Gisev N, et al. The accessibility of pharmacist prescribing and impacts on medicines access: a systematic review. Res Social Adm Pharm. 2024. https:\/\/doi.org\/10.1016\/j.sapharm.2024.01.006.","journal-title":"Res Social Adm Pharm"},{"key":"2084_CR37","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp150771","author":"EM Hawes","year":"2016","unstructured":"Hawes EM, Misita C, Burkhart JI, et al. Prescribing pharmacists in the ambulatory care setting: experience at the University of North Carolina Medical Center. Am J Health-Syst Pharm. 2016. https:\/\/doi.org\/10.2146\/ajhp150771.","journal-title":"Am J Health-Syst Pharm"},{"key":"2084_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-10-313","author":"MR Law","year":"2010","unstructured":"Law MR, Morgan SG, Majumdar SR, et al. Effects of prescription adaptation by pharmacists. BMC Health Serv Res. 2010. https:\/\/doi.org\/10.1186\/1472-6963-10-313.","journal-title":"BMC Health Serv Res"},{"key":"2084_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2020.05.005","author":"F Al Raiisi","year":"2021","unstructured":"Al Raiisi F, Stewart D, Ashley C, et al. A theoretically based cross-sectional survey on the behaviors and experiences of clinical pharmacists caring for patients with chronic kidney disease. Res Social Adm Pharm. 2021. https:\/\/doi.org\/10.1016\/j.sapharm.2020.05.005.","journal-title":"Res Social Adm Pharm"},{"key":"2084_CR40","first-page":"217","volume":"8","author":"L Emmerton","year":"2005","unstructured":"Emmerton L, Marriott J, Bessell T, et al. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8:217\u201325.","journal-title":"J Pharm Pharm Sci"},{"key":"2084_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9091098","author":"L Al-Abdelmuhsin","year":"2021","unstructured":"Al-Abdelmuhsin L, Al-Ammari M, Babelghaith SD, et al. Assessment of pharmacists\u2019 knowledge and practices towards prescribed medications for dialysis patients at a tertiary hospital in Riyadh Saudi Arabia. Healthcare. 2021. https:\/\/doi.org\/10.3390\/healthcare9091098.","journal-title":"Healthcare"},{"key":"2084_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae221","author":"A Ardavani","year":"2024","unstructured":"Ardavani A, Curtis F, Hopwood E, et al. Effect of pharmacist interventions in chronic kidney disease: a meta-analysis. Nephrol Dial Transplant. 2024. https:\/\/doi.org\/10.1093\/ndt\/gfae221.","journal-title":"Nephrol Dial Transplant"},{"key":"2084_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-019-00816-4","author":"F Al Raiisi","year":"2019","unstructured":"Al Raiisi F, Stewart D, Fernandez\u2010Llimos F, et al. Clinical pharmacy practice in the care of chronic kidney disease patients: a systematic review. Int J Clin Pharm. 2019. https:\/\/doi.org\/10.1007\/s11096-019-00816-4.","journal-title":"Int J Clin Pharm"},{"key":"2084_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jppr.70006","author":"R Livori","year":"2025","unstructured":"Livori R, Shaji C, Tran DGN, et al. Renal clinical pharmacy services and outcomes for patients on dialysis: a scoping review. J Pharm Pract Res. 2025. https:\/\/doi.org\/10.1002\/jppr.70006.","journal-title":"J Pharm Pract Res"},{"key":"2084_CR45","first-page":"255","volume":"16","author":"VA Lambert","year":"2012","unstructured":"Lambert VA, Lambert CE. Editorial: qualitative descriptive research: an acceptable design. Pac Rim Int J Nurs Res Thail. 2012;16:255\u20136.","journal-title":"Pac Rim Int J Nurs Res Thail"},{"key":"2084_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"key":"2084_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/1098214005283748","author":"DR Thomas","year":"2006","unstructured":"Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006. https:\/\/doi.org\/10.1177\/1098214005283748.","journal-title":"Am J Eval"},{"key":"2084_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-93","author":"R Islam","year":"2012","unstructured":"Islam R, Tinmouth AT, Francis JJ, et al. A cross-country comparison of intensive care physicians\u2019 beliefs about their transfusion behaviour: a qualitative study using the theoretical domains framework. Implement Sci. 2012. https:\/\/doi.org\/10.1186\/1748-5908-7-93.","journal-title":"Implement Sci"},{"key":"2084_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-9-31","author":"K Murphy","year":"2014","unstructured":"Murphy K, O\u2019Connor D. Understanding diagnosis and management of dementia and guideline implementation in general practice: a qualitative study using the theoretical domains framework. Implement Sci. 2014. https:\/\/doi.org\/10.1186\/1748-5908-9-31.","journal-title":"Implement Sci"},{"key":"2084_CR50","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.3346","author":"R Almawed","year":"2023","unstructured":"Almawed R, Shiu J, Bungard T, et al. Pharmacist prescribing at inpatient discharge in Alberta. Can J Hosp Pharm. 2023. https:\/\/doi.org\/10.4212\/cjhp.3346.","journal-title":"Can J Hosp Pharm"},{"key":"2084_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2020.02.006","author":"IRF Van Berlo-Van De Laar","year":"2020","unstructured":"Van Berlo-Van De Laar IRF, Sluiter HE, Riet E, et al. Pharmacist-led medication reviews in pre-dialysis and dialysis patients. Res Social Adm Pharm. 2020. https:\/\/doi.org\/10.1016\/j.sapharm.2020.02.006.","journal-title":"Res Social Adm Pharm"},{"key":"2084_CR52","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp150080","author":"T Heck","year":"2015","unstructured":"Heck T, Gunther M, Bresee L, et al. Independent prescribing by hospital pharmacists: patterns and practices in a Canadian province. Am J Health Syst Pharm. 2015. https:\/\/doi.org\/10.2146\/ajhp150080.","journal-title":"Am J Health Syst Pharm"},{"key":"2084_CR53","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v74i3.3151","author":"V Vuong","year":"2021","unstructured":"Vuong V, Bhojwani R, Sengar A, et al. Prescription modification by pharmacists in a hospital setting: are Ontario pharmacists ready? CJHP. 2021. https:\/\/doi.org\/10.4212\/cjhp.v74i3.3151.","journal-title":"CJHP"},{"key":"2084_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2024.100418","author":"T Zhang","year":"2024","unstructured":"Zhang T, Mohsen M, Abbaticchio A, et al. Patients\u2019 experiences of medication management while navigating ongoing care between outpatient services: a qualitative case study of patients on hemodialysis. Explor Res Clin Soc Pharm. 2024. https:\/\/doi.org\/10.1016\/j.rcsop.2024.100418.","journal-title":"Explor Res Clin Soc Pharm"},{"key":"2084_CR55","doi-asserted-by":"publisher","DOI":"10.1177\/20543581241309986","author":"MD Talson","year":"2025","unstructured":"Talson MD, Ferreira Da Silva P, Finlay J, et al. Patient, caregiver, and provider perspectives on improving provider-patient interactions in hemodialysis: a qualitative study. Can J Kidney Health Dis. 2025. https:\/\/doi.org\/10.1177\/20543581241309986.","journal-title":"Can J Kidney Health Dis"},{"key":"2084_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riae013.009","author":"B Brennan","year":"2024","unstructured":"Brennan B, Strawbridge J, Stewart D, et al. An umbrella review of pharmacist prescribing: stakeholders\u2019 views and impact on patient outcomes. Int J Pharm Pract. 2024. https:\/\/doi.org\/10.1093\/ijpp\/riae013.009.","journal-title":"Int J Pharm Pract"},{"key":"2084_CR57","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp150786","author":"M Gray","year":"2016","unstructured":"Gray M, Mysak T. The road to pharmacist prescribing in Alberta Health Services. Am J Health Syst Pharm. 2016. https:\/\/doi.org\/10.2146\/ajhp150786.","journal-title":"Am J Health Syst Pharm"},{"key":"2084_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-8-109","author":"M Makowsky","year":"2013","unstructured":"Makowsky M, Guirguis L, Hughes C, et al. Factors influencing pharmacists\u2019 adoption of prescribing: qualitative application of the diffusion of innovations theory. Implement Sci. 2013. https:\/\/doi.org\/10.1186\/1748-5908-8-109.","journal-title":"Implement Sci"},{"key":"2084_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/ijpp.12557","author":"M Zhou","year":"2019","unstructured":"Zhou M, Desborough J, Parkinson A, et al. Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences. Int J Pharm Pract. 2019. https:\/\/doi.org\/10.1111\/ijpp.12557.","journal-title":"Int J Pharm Pract"},{"key":"2084_CR60","unstructured":"Medication reconciliation as a strategic priority. Accreditation Canada. 2022. https:\/\/physicians.nshealth.ca\/sites\/default\/files\/2022-05\/NSHealth%20Medication%20Reconciliation%20One%20Pager.pdf. Accessed 26 Mar 2025."},{"key":"2084_CR61","unstructured":"The patient-centred medical home: integrating comprehensive medication management to optimize patient outcomes: resource guide. In: Patient-Centred Primary Care Collaborative. 2nd ed. 2012. www.pcpcc.org\/sites\/default\/files\/media\/medmanagement.pdf. Accessed 26 Mar 2025."},{"key":"2084_CR62","doi-asserted-by":"publisher","DOI":"10.1007\/s10903-018-0816-4","author":"A Yeheskel","year":"2019","unstructured":"Yeheskel A, Rawal S. Exploring the \u2018patient experience\u2019 of individuals with limited English proficiency: a scoping review. J Immigr Minor Health. 2019. https:\/\/doi.org\/10.1007\/s10903-018-0816-4.","journal-title":"J Immigr Minor Health"},{"key":"2084_CR63","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2020.40","author":"H Al Shamsi","year":"2020","unstructured":"Al Shamsi H, Almutairi AG, Mashrafi SA, et al. Implications of language barriers for healthcare: a systematic review. Oman Med J. 2020. https:\/\/doi.org\/10.5001\/omj.2020.40.","journal-title":"Oman Med J"},{"key":"2084_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2018.05.006","author":"R Naef","year":"2018","unstructured":"Naef R, Ernst J, B\u00fcrgi C, et al. Quality of acute care for persons with cognitive impairment and their families: a scoping review. Int J Nurs Stud. 2018. https:\/\/doi.org\/10.1016\/j.ijnurstu.2018.05.006.","journal-title":"Int J Nurs Stud"},{"key":"2084_CR65","doi-asserted-by":"publisher","DOI":"10.1111\/jpm.12987","author":"SR Velmans","year":"2023","unstructured":"Velmans SR, Joseph C, Wood L, et al. A systematic review and thematic synthesis of inpatient nursing staff experiences of working with high-risk patient behaviours. J Psychiatr Ment Health Nurs. 2023. https:\/\/doi.org\/10.1111\/jpm.12987.","journal-title":"J Psychiatr Ment Health Nurs"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-02084-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:16:10Z","timestamp":1778746570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-02084-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2084"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-02084-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8109125\/v1","asserted-by":"object"}]},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study received approval from the University Health Network Research Ethics Board (Study ID: 25-5303).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}